Complement C3/C3aR Signaling Pathway Inhibition Ameliorates Retinal Damage in Experimental Retinal Vein Occlusion
The complement C3/C3aR signaling pathway is critically involved in RVO-induced retinal damage and targeting this pathway may be a promising approach for RVO treatment.
Authors
- Heping Xu (ORCID: https://orcid.org/0000-0003-4000-931X)
- Zhengwei Ge (ORCID: https://orcid.org/0000-0003-0906-9576)
- Juan Chen (ORCID: https://orcid.org/0000-0001-6920-7972)
- Zhongping Chen (ORCID: https://orcid.org/0000-0002-5289-1584)
- Hengwei Liu
- Yufan Zhou (ORCID: https://orcid.org/0000-0003-2607-2718)
- Yanying Zhao
- Tingting Guo
Institutions
- Queen's University Belfast (GB)
- Central South University (CN)
- Jinan University (CN)
- Hubei University of Science and Technology (CN)
- He Eye Hospital (CN)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1167/iovs.66.5.2
- Citations
- 3
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.12